Jiangsu Recbio Technology Co., Ltd. Profile Avatar - Palmy Investing

Jiangsu Recbio Technology Co., Ltd.

Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People's Republic of China. The company is developing vaccines for the treatment of cervical cancer and genital…
Biotechnology
CN, Taizhou [HQ]

Balance Sheet

5 Sheets · From 2023 to 2019
Configuration
In Million CNY. Margins, Growth Rates In %
Metric 2019 2020 2021 2022 2023
Assets
426.00 1,047.00 1,919.00 2,309.00 2,186.00
Current
310.00 709.00 1,294.00 1,419.00 1,129.00
Non Current
115.00 337.00 624.00 889.00 1,056.00
Liabilities
746.00 2,055.00 245.00 656.00 1,115.00
Current
17.00 57.00 139.00 328.00 444.00
Non Current
728.00 1,998.00 106.00 327.00 671.00
Equity
-319.00 -1,008.00 1,673.00 1,653.00 1,070.00
Stockholders' Equity
-319.00 -1,008.00 1,673.00 1,661.00 1,071.00
Retained Earnings
-193.00 -373.00 -1,030.00 -1,753.00 -2,334.00
Common Stock
29.00 36.00 448.00 482.00 482.00
Preferred Stock
647.00 1,843.00 - - - - - -
Profit
-203.00 -211.00 -702.00 -719.00 -571.00
Dividends
- - - - - - - - - -
Minority Interest
- - - - - - -8.00 - -
Other Stockholders' Equity
-155.00 -671.00 1,954.00 2,583.00 2,529.00
Loss Other Compr. Income
-647.00 -1,843.00 301.00 349.00 393.00